Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 02, 2023
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 11,917 $ 14,889
Accounts receivable, net 1,766 1,689
Inventory 1,320 1,387
Asset held for sale 732 732
Other current assets 2,724 2,526
Total Current Assets 18,459 21,223
Property & equipment, net 19,371 29,035
Operating right-of-use assets, net 45,741 0
Goodwill 31,621 98,000
Intangible assets, net 160,208 168,723
Other assets 1,380 738
Total Assets 276,780 317,719
Current Liabilities    
Accounts payable - trade and other 8,464 7,841
Accrued expenses 10,589 5,302
Short-term operating lease liability 9,924 0
Other liabilities 6,241 7,856
Short-term borrowings 4,985 3,331
Total Current Liabilities 40,203 24,330
Non-Current Liabilities    
Long-term borrowings 53,794 56,797
Redeemable preferred stock, $0.0001 par value, 10,000,000 shares authorized, 2,120,000 shares issued and outstanding, $53 million principal redemption value 51,418 47,525
Long-term operating lease liability 40,748 0
Related party note payable 9,235 8,724
Warrant liability 195 2,706
Other non-current liabilities 1,017 3,009
Deferred income taxes 1,223 1,353
Total Liabilities 197,833 144,444
Commitments and Contingencies - Note 7
Stockholders' Equity    
Common stock, $0.0001 par value, 100,000,000 shares authorized, 22,257,772 and 21,303,500 shares issued and outstanding as of January 2, 2023 and December 31, 2021, respectively 2 2
Additional paid-in capital 306,096 296,992
Accumulated deficit (227,151) (123,719)
Total Stockholders' Equity 78,947 173,275
Total Liabilities and Stockholders' Equity $ 276,780 $ 317,719
Common stock, shares issued 22,257,772 21,303,500
Common stock, shares outstanding 22,257,772 21,303,500
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000